Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa

Journal of Molecular Endocrinology

Volumn 34, Issue 3, 2005, Pages 809-823

  Bradford, C Samuel ^a   Walthers, Eliza A ^a   Searcy, Brian T ^a   Moore, Frank L ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; BRAIN RECEPTOR; BRL 52537; COMPLEMENTARY DNA; DELTA OPIATE RECEPTOR AGONIST; DYNORPHIN[1-13]; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NOCICEPTIN; NORBINALTORPHIMINE; OPIOID RECEPTOR LIKE 1 RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; DRUG SELECTIVITY; GENE EXPRESSION; MAMMAL; MOLECULAR CLONING; NEWT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RECEPTORS, OPIOID, KAPPA; SALAMANDRIDAE; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 21344473009     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01711     Document Type: Article

References (75)

1. Akil H, Meng F, Mansour A, Thompson R, Xie GX & Watson S 1996 Cloning and characterization of multiple opioid receptors. NIDA Research Monograph 161 127-140.
2. Angers S, Salahpour A & Bouvier M 2002 Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annual Review of Pharmacology and Toxicology 42 409-435.
3. Benyhe S, Varga E, Hepp J, Magyar A, Borsodi A & Wollemann M 1690 Characterization of kappa 1 and kappa 2 opioid binding sites in frog (Rana esculenta) brain membrane preparation. Neurochemistry Research 15 899-904.
4. 3H]ethylketocyclazocine. Life Sciences 51 1647-1655.
5. 3H]dynorphin-8 binding sites in frog (Rana esculenta) brain membranes. Neuropeptides 26 359-364.
6. Bloom FE 1983 The endorphins: a growing family of pharmacologically pertinent peptides. Annual Review of Pharmacology and Toxicology 23 151-170.
7. Borsodi A, Khan A, Simon J, Benyhe S, Hepp J, Wollemann M & Medzihradszky K 1986 Purification of kappa-opioid receptor subtype to apparent homogeneity from frog brain. NIDA Research Monograph 75 1-4.
8. Chavkin C, James IF & Goldstein A 1982 Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215 413-415.
9. Chen Y, Mestek A, Liu J & Yu L 1993 Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochemical Journal 295 625-628.
10. Clark JA, Liu L, Price M, Hersh B, Edelson M & Pasternak GW 1989 Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype. Journal of Pharmacology and Experimental Therapeutics 251 461-468.
11. Cone RI & Goldstein A 1982 A dynorphin-like opioid in the central nervous system of an amphibian. PNAS 79 3345-3349.
12. Danielson PB, Hoversten MT, Fitzpatrick M, Schreck C, Akil H & Dores RM 2001 Sturgeon orphanin, a molecular 'fossil' that bridges the gap between the opioids and orphanin FQ/nociceptin. Journal of Biological Chemistry 276 22114-22119.
13. Darlison MG, Greten FR, Harvey RJ, Kreienkamp HJ, Stuhmer T, Zwiers H, Lederis K & Richter D 1997 Opioid receptors from a lower vertebrate (Catostomus commersoni): sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution. PNAS 94 8214-8219.
14. Dean MK, Higgs C, Smith RE, Bywater RP, Snell CR, Scott PD, Upton GJ, Howe TJ & Reynolds CA 2001 Dimerization of G-protein-coupled receptors. Journal of Medical Chemistry 44 4393-4614.
15. Deviche P & Moore FL 1987 Opioid kappa-receptor agonists suppress sexual behaviors in male rough-skinned newts (Taricha granulosa). Hormones and Behavior 21 371-383.
16. Deviche P, Lowry CA & Moore FL 1989 Opiate control of spontaneous locomotor activity in a urodele amphibian. Pharmacology, Biochemistry, and Behavior 34 753-757.
17. Deviche P, Cotter P & Gulledge CC 1993 Identification, partial characterization, and hypothalamic distribution of kappa, mu, and delta opioid receptors in a passerine songbird (Junco hyemalis). Brain Research 614 220-226.
18. Evans SJ, Searcy BT & Moore FL 2000 A subset of kappa opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain. Endocrinology 141 2294-2300.
19. Felsenstein J 1989 PHYLIP - Phylogeny Inference Package (Version 3-2). Cladistics 5 164-166.
20. Felsenstem J 2004 PHYLIP (Phylogeny Inference Package) version 3.6. Distributed by the author. Department of Genome Sciences, University of Washington, Seattle, WA.
21. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G & O'Dowd BF 2000 Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. Journal of Biological Chemistry 275 26128-26135.
22. Goldstein A & Naidu A 1989 Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Molecular Pharmacology 36 265-272.
23. Janecka A, Fichna J & Janecki T 2004 Opioid receptors and their ligands. Current Topics in Medicinal Chemistry 4 1-17.
24. Jordan BA & Devi LA 1999 G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 697-700.
25. Kozak M 1989 The scanning model for translation: an update. Journal of Cell Biology 108 229-241.
26. Krogh A, Larsson B, von Heijne G & Sonnhammer EL 2001 Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. Journal of Molecular Biology 305 567-580.
27. Lahti RA, VonVoigtlander PF & Barsuhn C 1982 Properties of a selective kappa agonist, U-50,488H. Life Sciences 31 2257-2260.
28. 3H]U-69393 a highly selective ligand for the opioid kappa receptor. European Journal of Pharmacology 109 281-284.
29. Lee SP, O'Dowd BF & George SR 2003 Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sciences 74 173-180.
30. Li X, Keith DE Jr & Evans CJ 1996 Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. FEBS Letters 397 25-29.
31. Lowry CA, Deviche P & Moore FL 1990 Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion. Brain Research 513 94-100.
32. Mansson E, Bare L & Yang D 1994 Isolation of a human kappa opioid receptor cDNA from placenta. Biochemical and Biophysical Research Communications 202 1431-1437.
33. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ & Akil H 1993 Cloning and pharmacological characterization of a rat kappa opioid receptor. PNAS 90 9954-9958.
34. Meng F, Taylor LP, Hoversten MT, Ueda Y, Ardati A, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O & Akil H 1996 Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. Journal of Biological Chemistry 271 32016-32020.
35. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B et al. 1995 Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 532-535.
36. Minami M & Satoh M 1995 Molecular biology of the opioid receptors: structures, functions and distributions. Neuroscience Research 23 121-145.
37. Minami M, Toya T, Katao Y, Maekawa K, Nakamura S, Onogi T, Kaneko S & Satoh M 1993 Cloning and expression of a cDNA for the rat kappa-opioid receptor. FEBS Letters 329 291-295.
38. Moller S, Croning MD & Apweiler R 2001 Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 17 646-653.
39. Moore FL & Miller LJ 1984 Stress-induced inhibition of sexual behavior: corticosterone inhibits courtship behaviors of a male amphibian (Taricha granulosa). Hormones and Behavior 18 400-410.
40. Moore FL & Orchinik M 1994 Membrane receptors for corticosterone: a mechanism for rapid behavioral responses in an amphibian. Hormones and Behavior 28 512-519.
41. Newman LC, Sands SS, Wallace DR & Stevens CW 2002 Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates. Journal of Pharmacology and Experimental Therapeutics 301 364-370.
42. Orchinik M, Murray TF & Moore FL 1991 A corticosteroid receptor in neuronal membranes. Science 252 1848-1851.
43. Orchinik M, Murray TF, Franklin PH & Moore FL 1992 Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. PNAS 89 3830-3834.
44. Owens CE & Akil H 2002 Determinants of ligand selectivity at the kappa-receptor based on the structure of the orphanin FQ receptor. Journal of Pharmacology and Experimental Therapeutics 300 992-999.
45. Pan YX, Bolan E & Pasternak GW 2002 Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype. Biochemical and Biophysical Research Communications 297 659-663.
46. Paterlini G, Portoghese PS & Ferguson DM 1997 Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation. Journal of Medicinal Chemistry 40 3254-3262.
47. Pfeiffer A, Brantl V, Herz A & Emrich HM 1986 Psychotomimesis mediated by kappa opiate receptors. Science 233 774-776.
48. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V & Schulz S 2002 Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. Journal of Biological Chemistry 277 19762-19772.
49. Piercey MF, Lahti RA, Schroeder LA, Einspahr FJ & Barsuhn C 1982 U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse. Life Sciences 31 1197-1200.
50. Raynor K, Kong H, Law S, Heerding J, Tallent M, Livingston F, Hines J & Reisine T 1996 Molecular biology of opioid receptors. NIDA Research Monograph 161 83-103.
51. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr & Civelli O 1995 Orphanin FQ a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270 792-794.
52. Reinscheid RK, Higelin J, Henningsen RA, Monsma FJ Jr & Civelli O 1998 Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. Journal of Biological Chemistry 273 1490-1495.
53. Reisine T & Bell GI 1993 Molecular biology of opioid receptors. Trends in Neuroscience 16 506-510.
54. Rothman RB, Bykov V, de Costa BR, Jacobson AE, Rice KC & Brady LS 1990 Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides 11 311-331.
55. Rozen S & Skaletsky H 2000 Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, pp 365-386. Eds S Krawetz & S Misener. Totowa, NJ: Humana Press.
56. Ruegg UT, Hiller JM & Simon EJ 1980 Solubilization of an active opiate receptor from Bufo marinus. European Journal of Pharmacology 64 367-368.
57. Ruegg UT, Cuenod S, Hiller JM, Gioannini T, Howells RD & Simon EJ 1981 Characterization and partial purification of solubilized active opiate receptors from toad brain. PNAS 78 4635-4638.
58. Simon EJ, Hiller JM, Groth J, Itzhak Y, Holland MJ & Beck SG 1982 The nature of opiate receptors in toad brain. Life Sciences 31 1367-1370.
59. Simon J, Szucs M, Benyhe S, Borsodi A, Zeman P & Wollemann M 1984 Solubilization and characterization of opioid binding sites from frog (Rana esculenta) brain. Journal of Neurochemistry 43 957-963.
60. Simon J, Benyhe S, Hepp J, Khan A, Borsodi A, Szucs M, Medzihradszky K & Wollemann M 1987 Purification of a kappa-opioid receptor subtype from frog brain. Neuropeptides 10 19-28.
61. Simon J, Benyhe S, Hepp J, Varga E, Medzihradszky K, Borsodi A & Wollemann M 1990 Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography. Journal of Neuroscience Research 25 549-555.
62. Simonin F, Gaveriaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattei MG, Charron G, Bloch B & Kieffer B 1995 kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. PNAS 92 7006-7010.
63. Stevens CW, Pezalla PD & Yaksh TL 1987 Spinal antinociceptive action of three representative opioid peptides in frogs. Brain Research 402 201-203.
64. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F & Higgins DG 1997 The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research 25 4876-4882.
65. Tortella FC, Rose J, Robles L, Moreton JE, Hughes J & Hunter JC 1997 EEG spectral analysis of the neuroprotective kappa opioids enadoline and PD117302. Journal of Pharmacology and Experimental Therapeutics 282 286-293.
66. Tusnady GE & Simon I 2001 The HMMTOP transmembrane topology prediction server. Bioinformatics 17 849-850.
67. Waldhoer M, Bartlett SE & Whistler JL 2004 Opioid receptors. Annual Review of Biochemistry 73 953-990.
68. Walthers EA, Bradford CS & Moore FL 2005 Cloning, pharmacological characterization, and tissue distribution of an ORLI-like opioid receptor from an amphibian, the rough-skinned newt Taricha granulosa. Journal of Molecular Endocrinology 34 247-256.
69. Wang JB, Johnson PS, Wu JM, Wang WF & Uhl GR 1994 Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. Journal of Biological Chemistry 269 25966-25969.
70. Whittaker VP 1969 The synaptosome. In Handbook of Neurochemistry, vol 2, pp 327-364. Ed. A Lathja. New York: Plenum.
71. Wollemann M, Benyhe S & Simon J 1993 The kappa-opioid receptor: evidence for the different subtypes. Life Sciences 52 599-611.
72. Xie GX, Meng F, Mansour A, Thompson RC, Hoversten MT, Goldstein A, Watson SJ & Akil H 1994 Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. PNAS 91 3779-3783.
73. Yakovlev AG, Krueger KE & Faden AI 1995 Structure and expression of a rat kappa opioid receptor gene. Journal of Biological Chemistry 270 6421-6424.
74. Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T & Bell GI 1993 Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. PNAS 90 6736-6740.
75. Zukin RS, Eghbali M, Olive D, Unterwald EM & Tempel A 1988 Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors. PNAS 85 4061-4065.